Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  SkyePharma PLC    SKP   GB00B3BFNB64

SKYEPHARMA PLC (SKP)

10
Delayed Quote. Delayed London Stock Exchange - 03/03 11:35:28 am
299.25 GBp   -2.52%
02/13 SKYEPHARMA : To Repay Remainder Of CRC Finance Facility Early
01/12DJSkyepharma Shares Fall as Royalties from GSK Lag
01/12 SKYEPHARMA : To Meet Expectations But Glaxo Royalties Slower
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
02/25/2015 02/26/2015 02/27/2015 03/02/2015 03/03/2015 Date
301(c) 303(c) 307.5(c) 307(c) 299.25 Last
29 781 79 224 56 648 107 374 184 403 Volume
-1.23% +0.66% +1.49% -0.16% -2.52% Change
More quotes
Company
SkyePharma Plc is a UK based pharmaceutical company.It engages in the research and development, licensing, manufacturing, marketing and distribution of prescription pharmaceutical products.The company approves products in the areas of oral, inhalation and topical delivery.SkyePharma was founded by... 
Sector
Pharmaceuticals
Calendar
03/10 | 08:15amPresentation
More about the company
Surperformance© ratings of SkyePharma PLC
Trading Rating : Investor Rating :
More Ratings
Chart SKYEPHARMA PLC
Duration : Period :
SkyePharma PLC Technical Analysis Chart | SKP | GB00B3BFNB64 | 4-Traders
Full-screen chart
Financials ( GBP)
Sales 2014 75,8 M
EBIT 2014 21,7 M
Net income 2014 -11,4 M
Finance 2014 15,1 M
Yield 2014 -
Sales 2015 97,3 M
EBIT 2015 25,9 M
Net income 2015 21,0 M
Finance 2015 34,4 M
Yield 2015 -
PER 2014 -
PER 2015 15,12
EV / Sales 2014 4,05x
EV / Sales 2015 2,95x
Capitalization 322 M
More Financials
Latest news on SKYEPHARMA PLC
02/13 SKYEPHARMA : To Repay Remainder Of CRC Finance Facility Early
01/12DJSkyepharma Shares Fall as Royalties from GSK Lag
01/12 SKYEPHARMA : To Meet Expectations But Glaxo Royalties Slower
2014 SKYEPHARMA : Launches Flutiform In Spain, Italy; New Product In Japan
2014 SKYEPHARMA : Says Sales Momentum Has Continued Since August
2014 SKYEPHARMA : Partner Announces Phase III Flutiform Study Results
2014 SKYEPHARMA : announces Interim Results 2014
2014 SKYEPHARMA : Holding(s) in Company
More news
Sector news Pharmaceuticals - NEC
01:10pDJMARKET SNAPSHOT : U.S. Stocks Retreat From Records After Netanyahu Speech
12:50p ABBVIE : FDA warning: men's testosterone drugs overused
12:21pDJMARKET SNAPSHOT : U.S. Stocks Retreat From Records After Netanyahu Speech
Plus d'actualités du secteur Pharmaceuticals - NEC


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF